The Intersection Among Torts, Science, Corporate Law, Insurance & Bankruptcy
The Myriad BRCA gene patent wars are continuing, and a new entrant has started a new fray by suing Myriad in a declaratory judgment suit. The Genomics Law Report provides a cogent summary.
“Patent think” continues to retrench and retrace after SCOTUS’ series of unanimous rulings that ended patents for discovery of laws of nature, and for most applications of math. A cogent summary of th
John Oliver has now covered patent trolls. The world continues to change.
Patent litigation is dropping, but remains a significant sector in the litigation industry. Links to patent litigation statistics are part of an October 29, 2014 post on patent litigation at Marginal